S

Spyros Chalkias

Moderna Therapeutics (United States)

ORCID: 0000-0002-6254-1158

Publishes on SARS-CoV-2 and COVID-19 Research, Animal Virus Infections Studies, vaccines and immunoinformatics approaches. 63 papers and 3.8k citations.

PubIndex Score98Top 2% · mid-careerHow it's scored

63Publications

3.8kTotal Citations

First publication: 1994First senior author: 2022

SARS-CoV-2 and COVID-19 Research Animal Virus Infections Studies vaccines and immunoinformatics approaches Alzheimer's disease research and treatments Viral gastroenteritis research and epidemiology

Top publicationsby citations

Two Randomized Phase 3 Studies of Aducanumab in Early Alzheimer's Disease

Samantha Budd Haeberlein, Alfred Sandrock, Bruno Vellas et al.|The Journal of Prevention of Alzheimer s Disease|2022

Cited by 1.3k

A Bivalent Omicron-Containing Booster Vaccine against Covid-19

Spyros Chalkias, Rituparna Das, Charles Harper et al.|New England Journal of Medicine|2022

Cited by 649

Amyloid-Related Imaging Abnormalities in 2 Phase 3 Studies Evaluating Aducanumab in Patients With Early Alzheimer Disease

Stephen Salloway, Karen Smirnakis, Spyros Chalkias et al.|JAMA Neurology|2021

Cited by 590

Safety, immunogenicity and antibody persistence of a bivalent Beta-containing booster vaccine against COVID-19: a phase 2/3 trial

Spyros Chalkias, Rituparna Das, Frank Eder et al.|Nature Medicine|2022

Cited by 144

Safety and Immunogenicity of XBB.1.5-Containing mRNA Vaccines

Spyros Chalkias, Rituparna Das, Nichole McGhee et al.|medRxiv|2023

Cited by 79